SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a loss of $6.4 million in its fourth quarter.
On a per-share basis, the Seattle-based company said it had a loss of 23 cents. Losses, adjusted for stock option expense, came to 16 cents per share.
The biotechnology company posted revenue of $9.1 million in the period.
For the year, the company reported that its loss narrowed to $52 million, or $1.86 per share. Revenue was reported as $57.4 million.
In the final minutes of trading on Thursday, the company's shares hit $4.49. A year ago, they were trading at $6.19.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC
Keywords: CTI BioPharma, Earnings Report